Semaglutide associated with blindness risk, study suggests Videos Semaglutide associated with blindness risk, study suggests01:52 | July 4, 2024 Doctors show CT scans of serious injuries as a result of e-scooter use02:13 | August 2, 2026 Rate of e-scooter injuries increasing in ERs, doctors say02:05 | August 1, 2026 Health Matters: West Nile risk increases in Hamilton, Ont.02:04 | July 31, 2026 Congo struggles to contain fastest-ever Ebola outbreak, as death toll passes 1,50001:47 | July 30, 2026 Health Matters: Health Canada grants injunction against unauthorized peptide producer02:13 | July 30, 2026 Dr
Understanding how ES influences brain development and if and how nutrition affects this process is essential for the development of effective nutritional therapies to improve long-term (mental) health in children exposed to ES
Zepbound is a brand-name drug prescribed for weight loss and long-term weight maintenance in certain adults with obesity or overweight
MASLD, metabolic dysfunction-associated steatotic liver disease
doi:10.1371/journal.pone.0198024